In the preceding report of this series (1) it was shown that the membrane immunofluorescence (MIF) reaction observed with cultured Burkitt's lymphoma (BL) cells (2, 3) depends apparently upon the presence of Epstein-Barr virus (EBV) (4) and to a considerable extent also upon the extent of the persistent EBV infection. Recent observations indicate that EBV is closely related to, if not identical with, the causative agent of infectious mononucleosis (IM). Antibodies to the virus were found to arise de novo in the course of the disease (5, 6) and continuous lines of blastoid cells derived from peripheral leukocytes of IM patients were shown to harbor regularly EBV (7) and to reveal in appreciable percentages of the cells the C group chromosomal marker (8) which was previously reported to be present in cultured BL cells (9, 10). It has not been possible to differentiate antigenically between the virus found in cultures of BL or IM cells by the methods employed thus far (11). It was of interest therefore to determine whether blastoid cells of BL and IM cultures would share membrane antigens detectable by the M I F test and, if found to be * These investigations were
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In the preceding report of this series (1) it was shown that the membrane immunofluorescence (MIF) reaction observed with cultured Burkitt's lymphoma (BL) cells (2, 3) depends apparently upon the presence of Epstein-Barr virus (EBV) (4) and to a considerable extent also upon the extent of the persistent EBV infection. Recent observations indicate that EBV is closely related to, if not identical with, the causative agent of infectious mononucleosis (IM). Antibodies to the virus were found to arise de novo in the course of the disease (5, 6) and continuous lines of blastoid cells derived from peripheral leukocytes of IM patients were shown to harbor regularly EBV (7) and to reveal in appreciable percentages of the cells the C group chromosomal marker (8) which was previously reported to be present in cultured BL cells (9, 10 ). It has not been possible to differentiate antigenically between the virus found in cultures of BL or IM cells by the methods employed thus far (11) . It was of interest therefore to determine whether blastoid cells of BL and IM cultures would share membrane antigens detectable by the M I F test and, if found to be true, whether IM patients would respond with formation of corresponding antibodies. Both questions were answered in the affirmative, as will be documented in this report.
Materials and Methods
Cd/s.--The establishment and maintenance of blastoid cell lines from peripheral leukocytes of IM patients (7) and from Burkitt tumor biopsies (12) have been fully described.
Sera.--Pertinent data on the BL patient serum Mutua employed as standard reagent have been recorded (1) . Sets of serial sera from IM patients were selected from those previously used for titrations of antibodies to EBV (5, 6) , and included a specimen taken prior to exposure and several others collected at various times after onset of illness. Additional sera were obtained from individuals with weN-documented attacks of IM as long as 20 yr ago. Control sera were derived from patients with varicella virus infections who possessed no antibodies to EBV.
Iramunofluorescence Tests.--The techniques employed for detection of membrane fluorescence (MIF), and EBV antigen-containing cells, as well as for titration of antibodies to EBV, have been fully described (i-3, 5, 13). The results of the MIF tests are expressed in terms of fluorescence indices (FI) which were calculated by the established formula (1) .
RESULTS

Membrane Fluorescence with Blastoid Cells Derived from Leukocytes of IM Patients
A total of eight blastoid cell cultures initiated with leukocytes of patients in the acute stage of IM were sent from Philadelphia to Stockholm. When shipped, the cultures were estimated to contain from 0.5 to 4% ceils which synthesized EBV antigen. These cultures were tested on arrival for membrane immunofluorescence with the aid of the standard serum of Burkitt tumor patient Mutua and then maintained further for subsequent assays. Table I records the initial results. The first six lines listed were strongly positive in the MIF test and the remaining two negative.
As has been pointed out (7), estimates of EBV-positive cells in relatively young cultures of IM ceils are often hampered by (a) considerable aggregation of the cells resulting in correspondingly dense and multilayered areas in cell smears; (b) relatively high percentages of dying or dead ceils which may reveal a granular, yellowish autofluorescence; and (c) presence of globulin-producing cells which may react in, and confuse, the results of indirect assays for viral antigen. Because of these difficulties, the percentages of EBV-positive ceils can be considered only approximations. It was noted furthermore (7) that the persistent EBV infections in IM cell cultures are more unstable generally than in established BL ceil lines. Once the IM cells commence to grow rapidly and are maintained under conditions for optimal cellular replication, the percentages of EBV-positive cells decline steeply. A similarly rapid decrease in MIF activity was seen with the first three IM cultures shipped to Stockholm. The results obtained with the E.H. IV line serve as an example (Fig. 1) . Within 5-6 wk of further cultivation in Stockholm, the FI values declined from >0.5 to <0.2. The line maintained in Philadelphia under similar conditions showed a decrease in EBV-positive cells from 2-3 to <0.2 %. The last five cultures listed in Table I were sent later, and these were maintained on a reduced feeding schedule, i.e., fed once every 7-10 days instead of at 4-7 day intervals. In these cultures, the MIF and EBV activities were retained although with some day by day fluctuations. For these reasons it became essential for determination of antibodies to membrane antigens to pretest all cells to be used for MIF reactions with the standard Mutua serum.
Development of Antibodies to Membrane Antigens of Cultured Burkitt Tumor Cells in Sera of I M _Patients
Sets of sera from patients with infectious mononucleosis, which included specimens collected several weeks to years before onset (5, 6) , were examined by the indirect immunofluorescence techniques (a) for antibodies to EB virus using acetone-fixed smears of cells from the EB 3 line of Burkitt tumor origin -? The above four sets of sera, as well as four additional ones, gave principally similar results regardless of the cell lines employed for the MIF test. With four other sets of sera, the results were not as uniform (Table II) . In these cases, MIF reactions were observed with the pre-IM sera and several of the cell lines employed so that the average FI values ranged from 0.10 to nearly 0.4. Nevertheless, subsequent sera, collected from 7 to 80 days after onset of illness, revealed substantial increases in the fluorescence indices. For every set of sera there was at least one cell line, however, which failed to react significantly with the pre-IM specimen but yielded very strong MIF reactions with the acute stage and later sera.
Additional tests were carried out with sera from (a) patients in the early and late acute stages of IM; (b) individuals who had well-documented histories of IM as long as 37 yr ago; and (c) children recently recovered from varicella which gave titers of <1:10 in the EBV reaction. The fluorescence indices obtained with the first group of sera from seven patients conformed to the patterns shown in Fig. 2 . The sera of the second group revealed anti-EBV titers ranging from 1: 20 to 1:160 (Table III) and highly significant FI values which were comparable to those obtained with the standard Mutua serum. The seven sera in the last group gave insignificant MIF reactions except for one which yielded an FI value of 0.45, but well below that of the Mutua serum control which was 0.82 in this set of tests.
Comparison of MIF Reactions Elicited by IM Patients' Sera in Cultured Burkitt Tumor and Infectious Mononucleosis Cells
The sets of sera from patients K. W. and E. H. were tested repeatedly for MIF activity using both cultured Burkitt tumor cells and ceils of lines derived from IM patients. It is seen (Table IV) that comparable results were obtained with both types of ceils from three lines each. The FI values rose from insigniticant levels in the pre-IM and early acute stage sera to highly significant figures in later sera. The peak values attained were of similar orders as those recorded with the Mutua control serum in both sets of ceils. A fourth IM ceil line (WHI) was included in one of the tests. These ceils failed to yield MIF reactions with the Mutua serum and the results with the sera of K. W. were likewise negative. Of special significance is the fact that patient E. H. developed antibodies which reacted not only with cell membrane antigens of Burkitt tumor cells but apparently equally well with blastoid ceils derived from cultures of her own leukocytes initiated 2 months after onset of her illness (5).
DISCUSSION
The above data indicate (a) that cultured blastoid cells derived from peripheral leukocytes of patients in the acute stage of infectious mononucleosis (IM) possess membrane antigens which are similar to, if not identical with, those found in Burkitt lymphoma (BL) cells from biopsies or continuous cultures; and (b) that patients with infectious mononucleosis develop antibodies to the membrane antigens of both types of ceils including autochthonous cell lines (E.H.). These findings extend earlier reports which showed (a) that established cell lines of either kind as a rule harbor EB virus particles in a fraction of the cells which thus far appear to be indistinguishable antigenically (11) and therefore certainly belong into the same subgroup of herpes viruses, if they do not represent a single type; and (b) that, in the course of IM, patients regularly form de novo antibodies to EBV as present in BL or IM cultures (11) .
Evidence has been presented in the preceding paper of this series (1) that EBV is linked, at least indirectly, to the elaboration of membrane antigens of BL cells and, as shown in the present report, a similar relation appears to hold also for cultured blastoid cells derived from leukocytes of IM patients. The membrane imrounofluorescence (MIF) reaction of cultured Burkitt tumor cells was shown to depend apparently on the presence of EBV and, to a considerable degree also upon the extent of the EBV infection in the cultures. Similarly, cultured blastoid ceils derived from IM patients revealed MIF activity if about 1% or more were EBV-positive. When the extents of the EBV infection declined on further maintenance of the cultures, the MIF test gradually turned negative.
There is little doubt that the antigen-antibody reactions involved in the two immunofluorescence tests are distinct as evident from several observation: (a) Generally, MIF-positive cells in both BL and IM cultures exceed EBV-positive ceils by a factor of 10 or greater; (b) cells from BL biopsies or early cultures may yield strong MIF with Burkitt tumor patients' sera even though few, if any, EBV-contalnlng cells may be detectable, whereas in well-established BL cultures the reverse may occasionally be found, i.e., relatively high percentages of EBV-positive cells in the absence of significant MIF activity (1) . Preliminary tests have shown that sera from IN[ patients may yield MIF reactions also with ceils from Burkitt tumor biopsies; and (c) early acute stage sera from IM patients may reveal already high, if not maximal, titers of antibodies to EBV, whereas significant and peak FI values are attained, as a nile, only in later sera. Thus, no constant relationship between the results of the two immunofluorescence tests became evident.
In the majority of IM patients studied, the choice of the target cells for the MIF reaction appeared to be immaterial. In a few patients, however, the pre-IM sera reacted to a considerable extent with the surface of some of the Burkitt tumor cell lines but not with others. This discrepancy is presently unexplained. It is, of course, possible that at times isoantigens may play a role in the test, (3). It is also conceivable that prolonged storage of sera in the frozen state may render them unsuitable for this test at least with cells from some of the lines employed. The four pre-IM sera which yielded such discrepant results were collected 6-9 yr previously, whereas five of the eight presera which did not present this problem had been stored for < 6 years.
As in the case of the EBV test (6), the MIF reactions are unrelated to heterophile antibodies because (a) sera of Burkitt tumor patients which react strongly in the MIF as well as EBV tests do not contain heterophile antibodies; (b) heterophile antibodies in IM arise as a rule earlier than those to membrane antigens; (c) antibodies active in the MIF and EBV tests seem to persist for years, if not for life, whereas heterophile antibodies disappear within months after onset of IM; and (~) exhaustive adsorption of IM patients' sera with sheep erythrocytes removes the heterophile antibodies without affecting the MIF and EBV reactions.
Neither the EBV found in BL or IM cultures nor the MIF reactions exhibited by both types of cells could thus far be distinguished antigenically. The question remains whether the virus, which apparently is causally related to IM, may also induce, directly or indirectly, Burldtt's lymphoma. The assumption that EBV represents merely a passenger in Burkitt tumors and cultures derived therefrom would be difficult to reconcile with the fact that all African Burkitt tumor patients studied to date had high levels of antibodies to EBV antigens (5, 13), whereas only about 50 % of the sera collected from comparable African control children reacted with EBV antigens (5, 14) and positive MIF tests are also less frequently observed with such sera (2, 3) .
SUMMARY
Blastoid cell cultures derived from leukocytes of patients in the acute stage of infectious mononucleosis (IM) and harboring Epstein-Barr (EB) virus in at least 1% of the cells were found to possess antigens in their membranes which presently are indistinguishable from those detected in Burkitt's lymphoma (BL) cells by the techniques employed. It was noted that, in the course of IM, antibodies are formed which react in indirect immunofluorescence tests with membrane antigens of live cells from Burkitt tumor lines as well as from IM leukocyte cultures, including an autochthonous line in the case of one patient. Sets of sera from IM patients were tested which included a serum collected weeks to years before onset of illness. In the majority of these the pre-IM serum failed to react in membrane immunofluorescence (MIF) tests with any of several Burkitt tumor cell lines employed, but in some cases the presera reacted with cells of some but not others of the lines. Possible explanations for these discrepant results have been discussed.
The antibodies involved in the MIF test are evidently distinct from those responsible for the EBV and heterophile reactions. Maximal MIF activity is attained long after the other two antibodies have reached maximal titers and antibodies to EBV and membrane antigens seem to persist for years whereas the heterophile reaction turns negative within a few months.
